Amphastar Pharma (NASDAQ: AMPH) reported Q2 Adj. EPS of $0.11, $0.04 better than the analyst estimate of $0.07. Revenue for the quarter came in at $65.2 million versus the consensus estimate of $63.3 million.

For earnings history and earnings-related data on Amphastar Pharma (AMPH) click here.